Long COVID' is a major dilemma, difficult to diagnose and even more challenging to treat. Millions are still being affected globally and ~10% of people experience Long COVID following acute infection. Many complain about fatigue, brain fog and mental difficulties, and ~200 symptoms are described making diagnosis difficult. Both acute COVID-19 and Long COVID can cause organ damage -involving the heart, lungs, kidneys, and brain; as well as inflammation, and studies suggest that severe COVID-19 is dominated by endothelial and immunological dysfunction, and immunothrombosis. Diagnostic tests for Long COVID are largely in development and finding effective therapies for Long COVID has been a major challenge; however, it is likely that antivirals have a role in preventing and treating Long COVID. Real-world data support the effectiveness of COVID-19 vaccines in reducing the risk of Long COVID. Long COVID remains a major challenge that needs considerable on-going research to determine effective treatments. The global public health emergency may be over but the fallout of Long COVID will be with us for some time.